Pyrimidin-2-ylamino-1H-pyrazols as LRRK2 inhibitors for use in the treatment of neurodegenerative disorders

MDE20260629A1Pending Publication Date: 2026-09-30DENALI THERAPEUTICS INC

View PDF 0 Cites 0 Cited by

Patent Information

Patent Timeline

24 May 2017

Priority

15 Jun 2017

Application

MDE20260629T

30 Sep 2026

Publication

MDE20260629A1

IPC: C07D403/12; C07D401/14; C07D405/14; C07D413/14; C07D403/14; C07D409/14; C07D417/14; C07D487/04; C07D491/20; C07D498/04; A61K31/506; A61K31/5365; A61K31/519; A61K31/5377; A61P25/00; A61P25/16; A61P25/28; A61P25/14; A61P35/00; A61P29/00

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Need to check novelty before this filing date? Find Prior Art

No text content released.